Normal Response to the Tissue-Type Plasminogen Activator After Venous Occlusion in a Fitzgerald Trait Patient

V Vicente García; A D’Angelo; P Seveso; I Alberca

doi:10.1055/s-0038-1657895

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1985; 54(02): 548
DOI: 10.1055/s-0038-1657895

Letter to the Editor

Schattauer GmbH Stuttgart

Normal Response to the Tissue-Type Plasminogen Activator After Venous Occlusion in a Fitzgerald Trait Patient

Authors

V Vicente García

Department of Haematology, University of Salamanca, Spain
A D’Angelo

^*Centro Angelo Bianchi Bonomi, University of Milan, Italy
P Seveso

^*Centro Angelo Bianchi Bonomi, University of Milan, Italy
I Alberca

Department of Haematology, University of Salamanca, Spain

Abstract

PDF Download

PDF (193 kb)

References

References
1 Colman WC. Surface-mediated defence reactions. The plasma contact activation system. J Clin Invest 1984; 73: 1249-1253
2 Saito H, Ratnoff OD, Donaldson VH. Defective activation of clotting, fibrinolytic and permeability-enhancing systems in human Fletcher trait plasma. Circ Res 1974; 34: 641-651
3 Griffin JH. Role of surface in surface-dependent activation of Hageman factor (Blood coagulation factor XII). Proc Natl Acad Sci 1978; 39: 263-283
4 Saito H, Ratnoff OD, Waldman R, Abraham JP. Deficiency of a hitherto unrecognized agent, Fitzgerald factor, participating in surface-mediated reactions of clottting, fibrinolysis, generation of kinins, and the property of diluted plasma-enhancing vascular permeability (PF/DIL). J Clin Invest 1975; 55: 1082-1089
5 España F, Aznar J, Estelles A. Factor XII-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher Factor deficient plasma gammaglobulin. J Lab Clin Med 1982; 100: 756-770
6 Estelles A, Aznar J, España F. The absence of release of the plasminogen activator after venous occlusion in a Fletcher trait patient. Thromb Haemostas 1983; 49: 66
7 Scott C, Colman RW. Function and immunochemistry of prekallikrein high molecular kininogen complex in plasma. J Clin Invest 1980; 65: 413-421
8 Schapira MA, Scott CF, Colman RW. Protection of human plasma kallikrein from inactivation C1 inhibitor and other protease inhibitors: The role of high molecular weight kininogen. Biochemistry 1981; 20: 2738-2743
9 Kluft C. Studies on the fibrinolytic system in human plasma: quantitative determination of plasminogen activators and proactivators. Thromb Haemostas 1979; 41: 365-383
10 Vicente V, Alberca I, Calles MI, Lopez BorrascaA. Effect of DDAVP on contact phase of blood coagulation. Br J Haematol 1984; 56: 679-684
11 Mancini G, Carbonaro AD, Heremans JF. Immunochemical quantitation of antigens by simple radial immunodiffusion. Immunochemistry 1965; 2: 235-254